CD80 and rheumatoid arthritis: CD80 and MHC II are important surface molecules involved in the activation of Ag-specific CD4+ T cells [40], which suggests that the anti-inflammatory activity of the CAP in RA may be mediated, at least in part, by the modulation of DCs.